STOCK TITAN
  1. Home
  2. Sec-filings
  3. GTBP
  4. [EFFECT] GT Biopharma, Inc. SEC Filing

[EFFECT] GT Biopharma, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 30, 2026 5:00 P.M.
Form: S-1
CIK: 0000109657
Company Name: GT Biopharma, Inc.
File Number: 333-292856

Source: View Original Filing on SEC EDGAR

Gt Biopharma Inc

NASDAQ:GTBP

View GTBP Stock Overview →

GTBP Rankings

#6262 Ranked by Market Cap
N/A Ranked by Dividends

GTBP Latest News

Mar 11, 2026
GT Biopharma to Participate in the 38th Annual Roth Conference
Mar 2, 2026
GT Biopharma Reports Full Year 2025 Financial Results
Feb 17, 2026
GT Biopharma to Present at the Centurion One Capital 9th Annual Toronto Growth Conference
Feb 3, 2026
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE®, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3
Jan 15, 2026
GT Biopharma Announces IND Submission for GTB-5550 TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers

GTBP Latest SEC Filings

Mar 6, 2026
[10-Q/A] GT Biopharma, Inc. Amended Quarterly Earnings Report
Mar 6, 2026
[10-Q/A] GT Biopharma, Inc. Amended Quarterly Earnings Report
Mar 2, 2026
[10-K] GT Biopharma, Inc. Files Annual Report
Mar 2, 2026
[8-K] GT Biopharma, Inc. Reports Material Event
Jan 30, 2026
[424B3] GT Biopharma, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)

GTBP Stock Data

14.67M
30.32M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN FRANCISCO